Evidence map›Paper›PMID 31138703›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2019

BCL6 modulates tissue neutrophil survival and exacerbates pulmonary inflammation following influenza virus infection.

Bibo Zhu, Ruixuan Zhang, Chaofan Li, Li Jiang, Min Xiang, Zhenqing Ye, Hirohito Kita, Ari M Melnick, Alexander L Dent, Jie Sun

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 73 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Bibo ZhuThoracic Diseases Research Unit, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic College of Medicine and Science, Rochester, MN 55905.ORCID 0000-0002-1187-4526
Ruixuan ZhangThoracic Diseases Research Unit, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic College of Medicine and Science, Rochester, MN 55905.
Chaofan LiThoracic Diseases Research Unit, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic College of Medicine and Science, Rochester, MN 55905.
Li JiangThoracic Diseases Research Unit, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic College of Medicine and Science, Rochester, MN 55905.
Min XiangThoracic Diseases Research Unit, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic College of Medicine and Science, Rochester, MN 55905.
Zhenqing YeDivision of Biomedical Statistics and Informatics, Mayo Clinic College of Medicine and Science, Rochester, MN 55905.
Hirohito KitaDepartment of Immunology, Mayo Clinic College of Medicine and Science, Rochester, MN 55905.
Ari M MelnickDepartment of Medicine, Division of Hematology & Medical Oncology, Weill Cornell Medicine, New York, NY 10065.
Alexander L DentDepartment of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN 46202.
Jie SunThoracic Diseases Research Unit, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic College of Medicine and Science, Rochester, MN 55905; sun.jie@mayo.edu.ORCID 0000-0002-2347-4511
Mayo Clinic · USCornell University · USIndiana University School of Medicine

Funding

Targeting Epigenetic Circuits in B-Cell LymphomasR35CA220499 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI MELNICK, ARI M. · 2018 to 2024
$7.2M
Mechanisms of Allergen-induced Type 2 ImmunityR37AI071106 · NIAID · MAYO CLINIC ROCHESTER · PI Hirohito Kita · 2018 to 2026
$5.2M
Molecular regulation of protective CD8 immunity against influenza infectionR01AI112844 · NIAID · UNIVERSITY OF VIRGINIA · PI SUN, JIE · 2015 to 2024
$4.5M
The control of allergic immune responses by follicular regulatory T cellsR01AI132771 · NIAID · INDIANA UNIVERSITY INDIANAPOLIS · PI DENT, ALEXANDER L · 2017 to 2021
$2.7M
Regulation of pulmonary anti-viral immunity in normal and obese hostsR01HL126647 · NHLBI · MAYO CLINIC ROCHESTER · PI SUN, JIE · 2015 to 2019
$1.9M
Simultaneously boosting both humoral and cellular immunity following vaccinationR01AG047156 · NIA · MAYO CLINIC ROCHESTER · PI SUN, JIE · 2015 to 2019
$1.6M
Targeting macrophage Bcl6 to enhance innate resistance to influenzaR21AI119612 · NIAID · MAYO CLINIC ROCHESTER · PI SUN, JIE · 2015 to 2016
$446k
NCI NIH HHS R35 CA220499NHLBI NIH HHS R01 HL126647NIAID NIH HHS R01 AI112844NIAID NIH HHS R01 AI132771NIAID NIH HHS R21 AI119612NIAID NIH HHS R37 AI071106NIA NIH HHS R01 AG047156
6 · The paper itself

Abstract

Neutrophils are vital for antimicrobial defense; however, their role during viral infection is less clear. Furthermore, the molecular regulation of neutrophil fate and function at the viral infected sites is largely elusive. Here we report that BCL6 deficiency in myeloid cells exhibited drastically enhanced host resistance to severe influenza A virus (IAV) infection. In contrast to the notion that BCL6 functions to suppress innate inflammation, we find that myeloid BCL6 deficiency diminished lung inflammation without affecting viral loads. Using a series of Cre-transgenic, reporter, and knockout mouse lines, we demonstrate that BCL6 deficiency in neutrophils, but not in monocytes or lung macrophages, attenuated host inflammation and morbidity following IAV infection. Mechanistically, BCL6 bound to the neutrophil gene loci involved in cellular apoptosis in cells specifically at the site of infection. As such, BCL6 disruption resulted in increased expression of apoptotic genes in neutrophils in the respiratory tract, but not in the circulation or bone marrow. Consequently, BCL6 deficiency promoted tissue neutrophil apoptosis. Partial neutrophil depletion led to diminished pulmonary inflammation and decreased host morbidity. Our results reveal a previously unappreciated role of BCL6 in modulating neutrophil apoptosis at the site of infection for the regulation of host disease development following viral infection. Furthermore, our studies indicate that tissue-specific regulation of neutrophil survival modulates host inflammation and tissue immunopathology during acute respiratory viral infection.

Indexed as

AnimalsApoptosisHost-Pathogen InteractionsInfluenza A virusLungMacrophages, AlveolarMiceMice, Inbred C57BLMice, KnockoutNeutrophil InfiltrationNeutrophilsOrthomyxoviridae InfectionsPneumoniaProto-Oncogene Proteins c-bcl-6Respiratory Tract InfectionsBcl6 protein, mouseProto-Oncogene Proteins c-bcl-6BCL6inflammationinfluenzaneutrophil

Identifiers

PMID31138703
PMCPMC6575592
OpenAlexW2946882077

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.